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Abstract
During the last decade, scale-up of vector control tools such as long-lasting insecticidal nets (LLINs) and indoor
residual spraying (IRS) contributed to the reduction of malaria morbidity and mortality across the continent.
Because these first line interventions are now affected by many challenges such as insecticide resistance, change in
vector feeding and biting behaviour, outdoor malaria transmission and adaptation of mosquito to polluted
environments, the World Health Organization recommends the use of integrated control approaches to improve,
control and elimination of malaria. Larviciding is one of these approaches which, if well implemented, could help
control malaria in areas where this intervention is suitable. Unfortunately, important knowledge gaps remain in its
successful application. The present review summarises key parameters that should be considered when
implementing larviciding efficacy or effectiveness trials.
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Background
The large scale implementation of vector control mea-
sures across Africa over the last decade has permitted a
decrease in malaria transmission and malaria burden.
According to recent reports by the World Health
Organization, up to 57 countries across the world have
reduced their malaria cases by 75% [1]. Reported malaria
mortality rates have fallen by 66% among all age groups
and by 71% among children under five [1, 2]. Some
countries across the world have over the last decade
reported elimination of the disease and many more are
advanced in this goal [1, 3]. Yet the disease remains
largely prevalent particularly in sub-Saharan Africa with
over 3.2 billion people still at risk of malaria. In 2015
over 214 million new malaria cases were reported with
438,000 deaths [1]. For countries still facing strong chal-
lenges affecting malaria control such as, rapid expansion
of insecticide resistance, outdoor malaria transmission,
change in vector feeding and biting behaviour, urban
malaria transmission or transmission in hotspots areas,
the use of additional control measures such as larval
control in an integrated control approach could appear
decisive for the control and elimination of the disease.
Several compounds including synthetic organic chemi-
cals, bacterial larvicides, spinosyns, insect growth regula-
tors can be used as larvicides [4]. Unfortunately, little
information is available on the efficacy and effectiveness
of the majority of these larvicides in African settings [5],
preventing the use of these tools by control programmes
[5]. The limited use of larval control tools for malaria
vector control could also be attributed to the poor
knowledge on methods of implementing and monitoring
the intervention, the assumed high operational costs of
this intervention, the intensive labour required for its
implementation and the short residual effect of previous
larvicides formulations [4]. Because larval control targets
mosquito at the larva stage it kills both outdoor and in-
door biting mosquitoes and could be a good supplement
to existing indoor base interventions such as LLINs or
IRS used as first line interventions. Larviciding with the
use of microbials such as Bacillus thuringiensis or Bacil-
lus sphaericus or a combination of the two have shown
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to be particularly efficient for controlling malaria vectors
in different epidemiological settings [6–10]. New formu-
lations in granules, microcapsules or briquettes present-
ing long residual effects or efficient against several
mosquitoes are now available and this, by reducing the
operational cost of this intervention, could encourage
more programmes to step in and use larval control fre-
quently as an additional measure for controlling malaria
transmission. This would be particularly the case in
urban settings where intervention could be cost-effective
[10, 11]. Yet according to recent reports, the number of
unbiased studies on the efficacy or the effectiveness of
larval control trials across Africa is still insignificant and
makes it difficult to draw generalized conclusions on this
intervention efficacy for malaria vector control [5, 12,
13]. The limited number of unbiased studies could come
from the imperfect knowledge on the procedures to de-
sign, implement and assess larval control efficacy or ef-
fectiveness trials. With the growing requirement for
clusters randomised trials (CRT) in vector control effi-
cacy or effectiveness trials, it becomes essential to recall
important guidelines to insure that, strong evidence is
reported from these studies. The aim of this paper is to
present a simple review of key parameters to consider
when implementing malaria vector larviciding efficacy or
effectiveness control interventions. The present review
will focus exclusively on larviciding implementation
which is defined by the World Health Organization [4],
as the regular application of biological or chemical in-
secticides in mosquitoes breeding habitats.
Larvicides for malaria vector control
According to the World Health Organization [4], several
compounds including oils and surface films, synthetic
organic chemicals, bacterial larvicides, spinosyns and in-
sect growth regulators can be used for larviciding.
Synthetic organic chemicals
This group includes all insecticides (organochlorines, py-
rethroids, organophosphates) that can be used for larval
control. Insecticides are neurotoxic compounds which
kill insects by interfering with the normal transmission
of nerve impulses [14] (Table 1). DDT has been largely
used across the world for indoor residual spraying and
larval control [15] but this compound is no longer used
in most parts of the world because of its persistence in
the environment and in organisms tissues, and its harm-
ful effect on humans and non-targets [16, 17]. Pyre-
throids were also used for larval control [4, 18, 19] but
due to risks of selection of insecticide resistance at larval
stage which could affect the performance of treated bed-
nets, they are no longer recommended [4]. Organopho-
phates (temephos, fenthion) are the only class of
insecticides approved for larval control because of their
high efficacy and low persistence in the environment [4].
They have been used successfully for mosquito and
black fly control [20–22]. New insecticide candidates de-
riving from plants extracts or essential oils are now
under study [23–25]. Many of these have been reported
to cause high larval mortality after ingestion or growth
inhibiting effects [25]. Yet just a few have undergone
chemical characterization and none have so far under-
gone field evaluations [23, 25].
Oils and surface films
Oils and surface films deriving from petroleum oil or
isotearyl alcohol could be used for larval control. The
application of petroleum oils in water is considered as
one of the ancient modes of control of mosquito larvae
[26]. From the 1920s through to the 1960s, petroleum
oils have been frequently used for mosquito larvae con-
trol in the Americas and in India [26–29]. Petroleum
products such as kerosene, petrol and engine oils are
still used in local communities in West Africa for con-
trolling the mosquito burden [30, 31]. Petroleum prod-
ucts are known to be active against mosquito larvae
through two mechanisms: direct toxicity and suffocation
[32]. However these oils present a certain number of
limits such as the non-uniform spreading of oils requir-
ing soluble surface active ingredients for their spreading
or their dispersion by wind or rain [33–35], their toxicity
to non-target organisms and to the environment [36,
37]. Derivatives such as monomolecular surface films
(MMF) have been developed over recent years to replace
petroleum oils and serve as larvicides and pupicides for
mosquitoes [32, 38]. These products are biodegradable
and spread spontaneously over large water surfaces to
form an ultrathin film preventing larvae from breathing
and therefore, induce suffocation and the death of larvae
[32, 38]. Their mode of action against mosquito larvae is
physical rather than chemical. They can affect both the
larval and the adult stages of the mosquito [39]. MMF
have been shown to be relatively safe to non-target and
aquatic organisms including humans. Several formula-
tions are available and await large scale field evaluation
[32, 38]. Yet the use of MMF in larval control is subject
to environmental challenges such as rainfall, wind and
vegetation which could induce dispersion and patchy
distribution of MMF layers on water surface [40].
Spinosyns
Spinosyns are products from the fermentation by Sac-
charopolyspora spinosa comprising spinosyn A (as the
main component) and spinosyn D (as the minor compo-
nent). These compounds act on the central nervous sys-
tem by binding to the nicotinic acetylcholine receptor
and GABA (gamma-aminobutyric acid) receptors inter-
rupting the normal transmission of nerve impulse [41].
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Spinosyns act through direct contact or after oral in-
gestion and are harmless to fish, mammals and birds
[41]. Due to the large spectrum of species that could
be targeted by these compounds including Lepidop-
tera, Diptera, cockroaches, spider mites, leafhoppers
and various insect orders [41–45], several applications
of spinosyns in veterinary, agriculture or human
health have been reported [41, 45, 46]. Spinosyns are
still not widely used for vector control [47], but are
used for pest control in agriculture [41]. Their use for
pest species control started in 1997. Few cases of
resistance have so far been reported in some pest
species and Drosophila melanogaster [48, 49].
Bacterial larvicides
These include organisms producing insecticidal crystal
proteins toxic for the mosquito which is particularly the
case for strains of Bacillus thurigiensis israelensis (Bti),
Bacillus sphaericus, Brevibacillus laterosporus and Clos-
tridium bifermentans [50, 51]. However only Bacillus
thurigiensis israelensis and Bacillus sphaericus are com-
monly used for vector control because of their high tox-
icity to mosquitoes and broad spectrum of target species
[4]. Bacterial larvicides act after ingestion by binding to
specific receptors in the larval midgut and induce spore
formation and larval death [50, 51] (Table 1). Due to
their specific mode of action, bacterial larvicides are
harmless to most aquatic non-target organisms and
humans and have been frequently used for larval con-
trol in Africa [6, 9, 52] and across the world [7, 44,
53]. Previous formulations requested frequent retreat-
ments whereas new formulations have a longer re-
sidual effect reaching up to six months and are
effective in organically polluted sites and on a large
spectrum of mosquito species [4, 10, 11].
Insect growth regulators (IGR)
Insect growth regulators include anti-juvenile hormone
agents which prevent the development of larvae or
pupae into adults (e.g. methoprene and pyriproxyfen)
and chitin synthesis inhibitors which kill larvae during
moulting (diblubenzuron and triflumeron) [4]. Some
IGR such as pyriproxyfen were also shown to have ovi-
cidal activity inhibiting egg hatching and development
[54, 55] or reducing the reproduction potential of adult
mosquitoes [56]. Most of these compounds have a lon-
ger residual effect lasting up to six months (Table 1).
They affect a large number of species. Most laboratory
tests conducted so far indicated high efficacy of the ma-
jority of compounds on Aedes, Culex or Anopheles spe-
cies [55–57]. However, their potential for malaria vector
larval control is still under investigation in Africa [38,
58–60]. A major limit to the use of IGR is the difficulty
to monitor the effectiveness of field treatments [4].
Important guidelines for the implementation of
larval control interventions
The World Health Organization [12] interim position on
the use of larval source management in sub-Saharan Af-
rica states that anti-larval measures can be cost-effective
in settings where breeding sites are few, fixed and find-
able. Larviciding in sub-Saharan Africa should be con-
sidered only as a supplement to the core interventions
(ITNs or IRS). As condition for its success, larviciding
need to be implemented in sites where malaria transmis-
sion is low to moderate, where there is a high coverage
with first line interventions such as IRS or LLINs. Larvi-
ciding is most likely to be appropriate for urban settings
because the conditions stated above are more likely to
be met and because the high population density make
the intervention cost effective [4]. Larviciding is an
intervention that needs to conform to local environ-
mental conditions. In certain circumstances when first
line control measures are not performing well in
cases of either high prevalence of insecticide resist-
ance, high transmission by outdoor biting mosquitoes,
a change in vector feeding and biting behaviour or
for controlling mosquito burden, the use of larvicid-
ing could prove to be appropriate [12].
Conducting a vector control intervention will require
the researcher to decide whether he wants to implement
an efficacy or an effectiveness control trial. According to
Flay et al. [61], an efficacy trial refers to the beneficial
effects of a programme or a policy delivered under opti-
mal conditions of delivery, whereas effectiveness trials
refer to the effects of a programme or policy under more
real-world conditions. This means that in an efficacy
trial, which could be considered as a pilot study, the re-
searcher will have as main objective to assess the per-
formance of the intervention when it is not significantly
affected by bias or confounding factors (under ideal con-
ditions of delivery). On the other hand, in an effective-
ness study, the researcher will assess whether the
intervention can be sustainable beyond the pilot stage or
can be extended to a larger geographical scale, he/she
can also focus on factors insuring performance, sustain-
ability and success of the intervention. In either case,
implementing a successful larviciding or vector control
trial will require that:
 A good study design is developed to address the
research question.
 A good sample size is defined for the study.
 A high quality of programme implementation and
monitoring is undertaken.
 Unbiased methods and standardized procedures are
used for data collection, processing and analysis.
 Appropriate statistical approaches are used for data
analysis.
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 Consistent positive effects without iatrogenic effect
are recorded.
 Long-term follow up are conducted before releasing
concluding remarks.
This requires that everything is well thought in ad-
vance when designing the study to ensure robustness of
concluding remarks.
Study design: use of Cluster Randomized Trial
(CRT) design
Although individual or collective measures can be used
as preventive measures for vector-borne diseases, evalu-
ation of these interventions are usually conducted at the
community level meaning that cluster randomized trials
are more appropriate for this purpose; these are consid-
ered as the most appropriate method to evaluate pre-
ventive interventions because they generate statistically
unbiased estimates and reduce the risk of selection bias
[62]. A two-arm parallel CRT design is actually the most
popularly used method in clinical trials and in vector
control interventions [6, 62]. In this type of study design,
clusters are individually allocated as treated or untreated
using either a random table or a computer assisted
programme. In case cluster allocation is not random,
one needs to adjust for pre-intervention differences to
minimise potential bias. This was done in the larval con-
trol trial in Dar es Salaam Tanzania where the authors
chose to allocate clusters as treated progressively accord-
ing to the ward supervisors and ward-based corps’ ability
to collect, understand, use and submit high quality data
during baseline studies [8, 9].
Because a loss of efficiency could occur when a two-
arm parallel CRT design is used, or due to the imbalance
of baseline outcomes distribution requiring statistical ad-
justments, many investigators prefer matching clusters
into pairs based on the similarity of baseline characteris-
tics before one in each pair is randomly assigned as
treated or untreated [63, 64]. This method is considered
to greatly reduce imbalances and increase the power of
detecting causal effect estimations [63–65]. Some larval
control trials have been conducted using this design [10,
63]. Complex designs can also be adopted depending on
the characteristics of factors to assess [66].
Randomized units arbitrarily defined as geographical
areas or clusters could be either define around key pa-
rameters of the study such as hospitals, rivers, hot spots
or just refer to a community, a district or a village as
was done in larval control trials conducted in Kenya,
Tanzania and Gambia [6, 8, 9, 52]. The boundaries of
each unit or cluster need to be clearly defined to avoid
overlapping and bias. When designing clusters, it is al-
ways important as for clinical trials, to define inclusion
and exclusion criteria. Making a list of what could be
considered as inclusion or exclusion criteria could be
helpful for cluster design and selection.
Research questions
Conducting a larval control trial requires as a prerequis-
ite the definition of a clear research question that will
enable good assessment of the intervention impact. Add-
itionally, drafting clear hypotheses and the target
(awaited impact) helps to determine what outcome
should be selected and measured. In the larval control
trial in western Kenya, Fillinger et al. [6] assumed their
intervention will reduce by 33% the incidence of new
Plasmodium infections in children. Clearly defining the
target enables identification of variables that could be
used as primary outcome.
Primary and secondary outcomes
The success of an intervention depends on the choice of
a set of reliable and sensitive outcomes capable of de-
tecting the impact of the intervention. In a study, de-
pending on the objectives, there is always a primary
outcome and several secondary outcomes. A primary
outcome represents the main variable enabling appreci-
ation of the overall impact of the intervention it is also
used for estimating the sample size. In vector control tri-
als investigators are tempted to use exclusively entomo-
logical outcomes [62], because these enable assessment
of the intervention impact when there are several inter-
ventions implemented in the same site [4]. In a system-
atic review assessing community effectiveness of
temephos for dengue vector control, out of 27 studies
analysed none assessed epidemiological outcomes [67].
Using both entomological and epidemiological outcomes
could provide a better understanding of the epidemio-
logical impact of the trial. Epidemiological outcomes are
considered as the best predictors to use for preventive
interventions because they allow a good assessment of
the intervention efficacy in protecting the human popu-
lation [62]. Epidemiological variables directly collected
from the field such as the prevalence or the incidence of
new malaria cases are considered as good indicators and
were used in several trials [6, 52]. Entomological vari-
ables, directly related to disease transmission can
provide a better understanding of the epidemiological
impact of the intervention [62]. Yet some outcomes such
as the Entomological Inoculation Rate, although provid-
ing detailed information on the transmission of the
disease from mosquitoes to humans, it is not recom-
mended to be used as a primary outcome because it is
an indirect measure of field collected variables in this
case it will be advisable to use adult mosquito density as
done in previous trials [6, 52].
Secondary outcomes can be as many as possible and
they must be reliable and sensitive. They can be either
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direct or indirect measures from the field depending
on the study objectives, and different sets of variables
could be measured. In larviciding studies conducted
in Kenya, Tanzania and in the Gambia, the authors
collected variables from households, entomological
and clinical surveys [6, 9, 52].
Sample size calculations
Calculating the sample size comes from the need to have
sufficient statistical power to detect differences between
the intervention and the control groups (minimising the
risk of type II error, the failure to detect a significant im-
pact of the intervention when there is truly one). Using
a smaller sample size will have a low precision as a dir-
ect consequence, whereas larger sample sizes will result
in the increased precision of measured parameters 95%
confidence interval. The lack of an effect during an
intervention could come from the fact that the study is
underpowered. This has been the case for many larvicid-
ing studies conducted so far in Africa using very few
clusters [5]. Studies using a minimum 80% power for
sample size estimation are generally considered reli-
able for entomological studies or clinical trials [68].
Also important is defining the significance level which
is the threshold for statistically significant outcomes.
The commonly used value in research is α = 0.05. If a
large number of comparisons are undertaken, the
Bonferroni correction should be applied to determine
the significance threshold to avoid Type 1 error (false
significant results) [69].
After defining the number of clusters, it is important
to determine the size of each cluster in order to minim-
ise as much as possible contamination or spillover ef-
fects. One strategy is, for example, to design clusters
very large and to sample and evaluate the intervention at
the centre of the cluster (Fig. 1). This design was
adopted in the Gambia, where Majambere et al. [52]
used large size clusters and sampled and evaluated their
intervention only in villages situated at the centre of
each cluster. However, the use of very large clusters
could require an increased sampling effort and could
affect implementation and monitoring of the interven-
tion particularly if inspections and treatment are done
manually and if breeding sites are numerous. According
to Hayes & Moulton [70] the use of a high number of
smaller clusters is better than using few big ones. A
minimum distance between clusters needs to be defined
in order to minimise as much as possible contamination
due to mosquito spillover from untreated to treated sites.
Most larviciding trials considered a minimum distance of
1 km between adjacent clusters as enough to minimise
contamination [6, 63]. In Kenya a reduction in the risk of
acquiring malaria infection of up to 56% was recorded be-
tween treated and untreated clusters situated 1 km apart
[6]. Moreover, because the measurement of epidemio-
logical outcomes could be subject to contamination due
to population movements from untreated to treated sites,
it is recommended to use a less mobile population such as
children as done in previous trials [6, 52].
Additionally, calculating the sample size will require
having prior information on the prevailing situation be-
fore the intervention to set a target (reduction level to
be achieved). This information could be retrieved from
previous reports conducted in the area [6]. In case the
information is not available, a preliminary study can be
conducted to collect this information. For CRT, sample
size calculations can be undertaken using formulas pro-
vided in Haye & Bennett [68] or elsewhere [66]. Yet after
sample size calculations, a certain number of simulations
need to be done to test the robustness of sample size
Fig. 1 Description of a cluster design during a larval efficacy trial in order to minimise contamination due to mosquito spillover
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estimations [68]. Simulations can be undertaken to verify
whether the sample size is appropriate in case of vari-
ation of the intercluster correlation coefficient k, in case
of violation of baseline assumptions, in case of variation
of clusters sizes or, in case the study achieves a target
lesser than estimated. It is always recommended to add
1 or 2 extra clusters per treatment group to take into
consideration lost to follow up or unforeseen changes,
which might be responsible for imbalance between
groups and systematic bias [66, 69].
Intracluster correlation coefficient (ICC)
The ICC could be defined as the measure of the homo-
geneity of observations within clusters of a random ef-
fect with respect to the dispersion of these observations
between clusters. It compares the variance within clus-
ters with the variance between clusters. It is calculated
by dividing the variance between clusters by the sum of
variance within and between clusters [71]. Estimates of
the ICC are very useful for sample size calculations.
Intercluster correlation coefficient
This variable (k) measures the level of variation between
clusters and is very important for sample size calcula-
tion. Because the variable is not readily available when
conducting a trial, Hayes & Bennett [68] recommend to
examine the required sample size for various plausible
values of k. Data collected from different field trials sug-
gest that k is often less or equal to 0.25 or does not nor-
mally exceed 0.5 for most health outcomes [68].
Data analysis and clustering adjustments
Clustering correlated data arise when there is a group
structure to the data or when the data present a hier-
archy with multilevel units. For example, in a longitu-
dinal larval control study, the repeated measurements
obtained from a single breeding site at different months
or seasons represent level 1 and the breeding sites repre-
sent level 2. Clustering adjustment enables correction,
for example, of certain types of random variation associ-
ated with sampling or sample under coverage or to ad-
just for probability of selection of household or of
participants taking part to the study [72]. Ignoring clus-
tering adjustments in analysis could lead to incorrect es-
timates of the standard error (SE) and type I error [73].
Although clustering has become common in most indi-
vidual randomised trials, it is not always accounted for
when assessing the intervention impact. In a review of
38 individually randomised clinical trials, the authors re-
ported that only 11% adjusted for clustering and that, of
the four that adjusted, three did not take into consider-
ation all sources of clustering [74]. The following could
lead to incorrect conclusions on the intervention impact
[73]. Clustering adjustments in regression models can be
introduced as random or fixed effects. In the Gambia
and Tanzania larval control trials, the authors chose to
include clustering adjustments as random effect during
data analysis [9, 52]. In order to investigate the ro-
bustness of their modelling assumptions and because
clusters were not allocated randomly, Maheu-Giroux
& de Castro [9] performed additional analysis consid-
ering individual random effects, clusters fixed effects,
and spatially-structured random effects. Further infor-
mation on how to perform clustering adjustments
during statistical analysis can be found in specialized
publications [72].
Because data collected during a CRT could be over-
dispersed or do not conform to normal distribution,
it is advisable to consider using robust methods such
as the negative binomial regression for data analysis
[75, 76]. Also important is ensuring that selected
statistical tests address the research question or the
hypothesis and are compatible with the type and dis-
tribution of the data. Classifying variables as categor-
ical, ordinal or continuous, to apply appropriate
statistical tests could be helpful [69].
Data collection
Data to collect during a larval control intervention has to
be undertaken before and during the intervention and
could include information from household, parasitological
and entomological surveys. All these data put together, en-
able a good understanding of the performance of the trial
and possible factors affecting the intervention.
Baseline data collection and randomization
Collecting baseline data during an intervention is key
because it enables to have well balanced groups before
implementing the study. It is recommended to carry out
baseline studies during a long period of about a year for
example, to capture seasonal or temporal variations that
could be responsible for misinterpretation of the inter-
vention impact [4]. If malaria transmission is seasonal,
baseline data collection can be undertaken during trans-
mission seasons as was done in previous trials in the
Gambia and Tanzania [9, 52]. Data collected describing
the characteristics of each group must be presented in a
detailed form, rather than presented as a text or in an
incomplete form as reported for some CRT [77]. Using
descriptive statistics for the presentation of baseline data
rather than just displaying the significance of statistical
tests between variables has the advantage that it allows
detailed characterisation of the level of dispersion of
each variable in each group and enables good compari-
son between groups [6, 52].
If at the end of baseline collections there is an imbal-
ance between treated and untreated clusters’ characteris-
tics meaning that randomization was unsuccessful, a
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selection of variables need to be undertaken to deter-
mine those that qualify for statistical adjustments. This
situation usually occurs when a two-arm parallel random
control trial design is used [64]. One way of solving the
imbalance is to compare all baseline characteristics be-
tween the groups and to consider variables with statisti-
cally significant differences [78, 79]. This approach
enables anticipation on statistical methods that can be
used to control for differences or on ways of considering
these differences when drawing conclusions about the
study. Because this method ignores variables that are
strongly correlated to the primary outcome but which
are not significantly different between groups [78, 79], it
is recommended in a first instance to consider variables
displaying high correlation with the primary outcome as
the most important [79]. A variable displaying a correl-
ation coefficient greater or equal to 0.3 with the primary
outcome is considered as suitable for statistical adjust-
ment [79]. Methods used to control for imbalance be-
tween groups include study design adjustments
(minimisation or stratification), matching of similar clus-
ter in pairs or statistical adjustments [64, 69, 80]. Also if
it is known in advance that a variable is strongly related
to the prognosis, it might be important to consider
adjusting for the variable during the study. For example,
in a larval control intervention, it might be important to
consider the usage rate of LLINs by the population or
IRS applications as important covariates because they
could influence the outcome of the study as observed in
previous studies [6].
Adult mosquito collections
In a malaria vector larval control intervention, mosquito
sampling has to be undertaken both at the adult and the
larval stages before and during the intervention to assess
the efficacy of the intervention. Conducting adult mos-
quito surveys at baseline provides knowledge on whether
mosquito populations are concentrated in certain geo-
graphical areas such as lowlands or if they are uniformly
distributed. Conducting these surveys during interven-
tion will determine whether the intervention is working
or if there are hot spot areas where transmission per-
sists. The major impact of a larval control intervention
is the reduction of adult mosquito densities. The World
Health Organization [4] recommends for adult mosquito
collection, that a high number of places per cluster
should be surveyed in order to capture all of the diver-
sity in the environment and to measure the average
community exposure. It is also important to carry repeti-
tive collections to avoid large variation due to environ-
mental factors such as rainfall [62]. According to Wilson
et al. [62] using automated methods for mosquito collec-
tion such as light traps as done by Majambere et al. [52],
reduces the risk of performance bias. On the other hand,
the use of human landing catches or spray collection
catches as reported in some trials [6, 8] could induce
performance bias because the abundance of catches de-
pends on the collector performance.
Larval collections
Larval surveys have to include the prospection of all
water pools, be it permanent or temporary breeding hab-
itats. Also, standardized procedures have to be defined
for larval collection. The use of a 350 ml dipper for esti-
mating larval densities in breeding habitats is recom-
mended. A standard number of dips should be
undertaken per size of the water collection. According
to the WHO [4] a dip could be enough for very small
water collections such as a footprint or hoofprint; for
larger water collection it is recommended to carry one
dip per square meter for a maximum of 30 dips [4]. All
these procedures have to be defined well in advance be-
fore conducting field collections. Also, for purpose of
standardization, the personnel involved in larval survey
have to be trained on how to distinguish between
Anopheles, Culex and Aedes larvae, how to carry out lar-
val collection, how to use field forms and on methods to
physically or ecologically characterise breeding sites.
After collection, the data should be introduced in a data-
base for further analysis. If possible, a geographic infor-
mation system (GIS) can be used to guide larval
collection; this tool is now widely used in vector control
trials [81–83]. The use of GIS technology has the advan-
tage that it allows development of detailed maps and a
clearly delineated system of numbering and logging of
larval data and enables visualization of the data and inte-
gration with other data sources such as case manage-
ment, adult mosquito collections or human behavioural
surveys [4, 81, 83].
During data collection qualitative and quantitative data
are collected from the field. It is recommended for quali-
tative variables not just to code them as present or ab-
sent but to register them according to their abundance.
This will allow their transformation into categorical vari-
ables for different statistical comparisons. This method
of registering qualitative field data was not always ap-
plied in most previous works [8, 52] whereas this could
improve statistical data analysis and interpretation.
Quality control analysis
Quality control of the product
Following the World Health Organization recommenda-
tions, only WHOPES approved compounds should be
used for larviciding efficacy or effectiveness trials [4]
because they have satisfied a certain number of require-
ments established by WHOPES such as stability,
potency, persistence in water bodies, reduced toxicity to
human and non-target organisms. The full list of
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recommended larvicides is available in the WHOPES
website (http://www.who.int/whopes/Mosquito_larvici-
des_28_July_2017.pdf ). Before using a larvicide, it is rec-
ommended to carry laboratory tests to verify if the
larvicide works well (whether the shipment or storage
have not affected the larvicide efficacy) and also to con-
firm the range of concentrations to use for treatments.
Quality control assessments need to be conducted be-
fore and during the intervention. Quality control assess-
ments conducted during the intervention will provide
information on the quality of the product during the
process of storage, the susceptibility level of the target
species, emergence of resistance and the influence of
long term used of the compound on target and non-
target organisms. Excluding few studies [84], the report-
ing of quality control assessment has not always been
mentioned [5] whereas this information could be im-
portant to understand the limited impact of an interven-
tion. Quality control tests have to be conducted with
both field populations and laboratory colonies to detect
more easily any variation. The methodology of conduct-
ing laboratory or semi-field tests could be found in
WHO guidelines for laboratory and field testing of mos-
quito larvicides [85] and in some reference published
works [84, 86, 87].
Quality assurance of the implementation
Observing quality control guidelines increase the de-
gree of confidence that the data collected is a true
picture of what is really taking place on the field and
is paramount for good evaluation of an intervention
impact. Because of their stringency, these guidelines
are not always followed in a high number of interven-
tions. In a systematic review and critical appraisal of
individualised random controlled trials conducted in
China in 2004, the authors reported out of 307 stud-
ies analysed that 64.8% failed to report on methods of
randomization, 82.4% did not mentioned blinding
their participants or investigators, inadequate reporting of
baseline data for a high proportion of studies and only
2.9% mentioned sample size calculations [77]. Similarly in
a Cochrane review on larviciding studies conducted up to
2012, the authors reported high risk of bias for almost all
studies conducted so far in Africa [5]. When conducting a
larviciding intervention, it is important to ensure that
methods used are greatly minimising the risk of bias and
confounders. For this reason, defining a detailed monitoring
strategy could be determinant. This includes:
(i). Having an independent group of assessors
monitoring the treatment of sites different from
those applying the larvicide on the field [88, 89];
(ii).Having within the personnel ensuring breeding site
treatments, a person supervising activities and
reporting on the successful completion of all
activities (this group has to be blinded to sites
chosen for random larval spot checks);
(iii). Conducting random larval spot-checks on a regular
basis at least once every month 24 or 48 h after each
treatment to verify if all breeding sites were targeted
and treated. According to the World Health
Organization [4], about 30 to 40 sites can be selected
each month per cluster for random larval spot
checks. It is also important to carry a follow-up in
some sentinel sites;
(iv). If the larvicide has a long residual effect (˃ 3 weeks)
such as Bti briquettes or insect growth regulators
[4], regular inspections of sites once weekly to
control the creation of new breeding habitats
particularly during the rainy season need to be
planned;
(v). Conducting regular adult mosquito collection in a
high number of places to ensure that breeding sites
treatment is effectively reducing adult mosquito
biting in houses.
Quality assurance of the implementation can be asso-
ciated to the use of a GIS system. This requires the ac-
quisition of appropriate software, construction of a GIS
database, acquisition of key material such as a server,
maps, computers and mobile devices. The tracking of
breeding habitats is undertaken using mobile devices.
After each inspection, information collected from the
field on breeding sites status (size, presence or absence
of larvae, larval density, physical or ecological character-
istics) are transferred in the GIS database. Reports of
monitoring activities are generated regularly to assess
the level of coverage of treatments. Untreated sites are
also monitored similarly to assess seasonal fluctuations.
Bias during larval control interventions
In their review of larviciding control interventions con-
ducted so far across Africa, Tusting et al. [5] identified a
certain number of biases that affected most larviciding
studies conducted on the continent. Table 2 presents the
most common biases that could affect a larval control
trial and ways of avoiding or minimising these biases.
Conclusions
Despite the progress registered during recent years, mal-
aria vector control efforts across Africa are still affected
by a high number of challenges including the spread of
insecticide resistance, change in vector feeding and
biting behaviours, outdoor malaria transmission and
adaptation of mosquitoes to polluted environments. It is
anticipated that additional control measures will be
needed to improve control and elimination of the dis-
ease. The use of larval control in an integrated control
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approach could be crucial for managing insecticide
resistance, for controlling outdoor biting mosquitoes
or for malaria elimination particularly in urban set-
tings where the intervention could be efficient and
cost-effective. The present review summarises key pa-
rameters to take into consideration when planning
and implementing larval control efficacy or effective-
ness trials in order to improve the success of these
interventions. The objective of the review was not to
go into in-depth explanation of concepts and methods
because this is available in several specialised docu-
ments, but to provide a document accessible to all
desiring to undertake successful larval control inter-
ventions. Because poor study design, even in an area
suitable for larviciding, will not achieve success, ap-
propriate study design, thoroughness and good imple-
mentation are all required to drive interventions
heading to malaria elimination across Africa.
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Table 2 A summary of common bias in larval control interventions and of ways for controlling these bias
No. Bias Corrective measures that could be applied
1 Random sequence generation (selection bias) A central randomization procedure could be applied for random larval
spot check. About 30 habitats randomly generated using a computer
assisted programme out of the total number of habitats can be
selected at least once monthly for each cluster by the programme
manager including habitat ID and coordinates. This information is
sent to the field supervisor for habitat inspection. Inspections have
to be undertaken 1 or 2 days after larviciding treatments according
to the timetable of treatments. For larvicides having a longer residual
effect, inspections has also to be undertaken at 6-7 days intervals.
2 Allocation of concealment (selection bias) Clusters have to be allocated as treated or untreated randomly. This
random allocation can be done using a random table or a computer
assisted programme.
3 Blinding of outcomes assessment (detection of bias) Data collectors and the personnel processing the sample in the
laboratory can be blinded to the intervention status.
4 Performance bias Field applicators can be blinded for the sites choose for random larval
spot check. Use automated methods for adult mosquito collection such
as light traps. Use standardized measures for estimating larval densities.
5 Incomplete outcome data (attrition bias) The sample size can be increased by adding 1 or 2 additional clusters
per treatment group. This bias if not important can also be solved
during statistical analysis.
6 Selective reporting (reporting bias) All measured outcomes showing either a positive, non-significant or
negative impact have to be reported as specified.
7 Baseline characteristics Baseline data including entomological, ecological data and human
behavioural data for each site has to be recorded before the intervention.
Adjustment for a set of covariates can be applied to control for chance
variations and improve precision of the impact estimates.
8 Contamination due to mosquito spillover Consider a buffer zone of at least 1 km between treated and untreated
clusters to minimise contamination due to mosquito spillover from
untreated to treated zones. In addition, clusters have to be designed
big enough so that the treatment is undertaken in the entire cluster
but the evaluation is conducted only in the centre of the cluster (Fig. 1).
10 Incorrect data analysis Use appropriate statistical methods and take into consideration during
data analysis the clustering effect, covariates and confounding factors
effects.
11 Sampling bias Sampling has to be conducted in households selected randomly, use a
large number of sites as possible for sampling, use automatic methods
for sampling, carry mosquito collection during several days for each
collection site to minimise bias due to rain or weather variations.
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